Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage? Mar 31, 2026 Life Science
Approved Catalyst Fuels Market Movement, Corcept Therapeutics Leads Healthcare Sector This Week Mar 27, 2026 Life Science
After Surging Over 100% in a Year, Executives Reduce Holdings Amid Adaptive Biotech’s Strong Performance Mar 27, 2026 Life Science
Under the Spotlight of GLP-1, the Hidden Risks of Eli Lilly’s High Valuation Cannot Be Ignored Mar 26, 2026 Life Science
After Five Years of Sluggish Performance, Pfizer Finds Renewed Hope in High Dividends and Clinical Data Mar 25, 2026 Life Science
A Pullback or a Buying Opportunity? Analyzing Vertex Pharmaceuticals’ Growth Drivers for the Coming Year Mar 25, 2026 Life Science
Jamieson Wellness: Unlocking the Investment Potential Behind the Green Cap Mar 18, 2026 Consumer Goods, Life Science
Oil CL=F tops $100, then slips as Gulf strikes snarl supply Mar 16, 2026 Consumer Goods, Life Science
